Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Petri M, Bruce IN, Dörner T, Tanaka Y, Morand EF, Kalunian KC, Cardiel MH, Silk ME, Dickson CL, Meszaros G, Zhang L, Jia B, Zhao Y, McVeigh CJ, Mosca M. Petri M, et al. Among authors: mosca m. Lancet. 2023 Mar 25;401(10381):1011-1019. doi: 10.1016/S0140-6736(22)02546-6. Epub 2023 Feb 24. Lancet. 2023. PMID: 36848919 Clinical Trial.
Systemic lupus erythematosus one disease or many?
Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Agmon-Levin N, et al. Among authors: mosca m. Autoimmun Rev. 2012 Jun;11(8):593-5. doi: 10.1016/j.autrev.2011.10.020. Epub 2011 Oct 25. Autoimmun Rev. 2012. PMID: 22041578 Review.
Treat-to-target in systemic lupus erythematosus: where are we today?
Mosca M, Boumpas DT, Bruce IN, Cervera R, Czirjak L, Dörner T, Houssiau F, Jacobsen S, Schneider M, Smolen JS, Voskuyl AE, van Vollenhoven RF. Mosca M, et al. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S112-5. Epub 2012 Nov 20. Clin Exp Rheumatol. 2012. PMID: 23072706
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.
van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirják L, Derksen R, Dörner T, Gordon C, Graninger W, Houssiau F, Inanc M, Jacobsen S, Jayne D, Jedryka-Goral A, Levitsky A, Levy R, Mariette X, Morand E, Navarra S, Neumann I, Rahman A, Rovensky J, Smolen J, Vasconcelos C, Voskuyl A, Voss A, Zakharova H, Zoma A, Schneider M. van Vollenhoven RF, et al. Among authors: mosca m. Ann Rheum Dis. 2014 Jun;73(6):958-67. doi: 10.1136/annrheumdis-2013-205139. Epub 2014 Apr 16. Ann Rheum Dis. 2014. PMID: 24739325
Off-label use of rituximab for systemic lupus erythematosus in Europe.
Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R. Rydén-Aulin M, et al. Among authors: mosca m. Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163. eCollection 2016. Lupus Sci Med. 2016. PMID: 27651920 Free PMC article.
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).
van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M. van Vollenhoven R, et al. Among authors: mosca m. Ann Rheum Dis. 2017 Mar;76(3):554-561. doi: 10.1136/annrheumdis-2016-209519. Epub 2016 Nov 24. Ann Rheum Dis. 2017. PMID: 27884822 Free article. Review.
Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration.
Tedeschi SK, Johnson SR, Boumpas D, Daikh D, Dörner T, Jayne D, Kamen D, Lerstrøm K, Mosca M, Ramsey-Goldman R, Sinnette C, Wofsy D, Smolen JS, Naden RP, Aringer M, Costenbader KH. Tedeschi SK, et al. Among authors: mosca m. Arthritis Care Res (Hoboken). 2018 Apr;70(4):571-581. doi: 10.1002/acr.23317. Epub 2018 Feb 22. Arthritis Care Res (Hoboken). 2018. PMID: 28692774 Free PMC article. Review.
Treat to target, remission and low disease activity in SLE.
Morand EF, Mosca M. Morand EF, et al. Among authors: mosca m. Best Pract Res Clin Rheumatol. 2017 Jun;31(3):342-350. doi: 10.1016/j.berh.2017.09.009. Epub 2017 Oct 13. Best Pract Res Clin Rheumatol. 2017. PMID: 29224676 Review.
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
Johnson SR, Khanna D, Daikh D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, Hiepe F, Sánchez-Guerrero J, Massarotti E, Boumpas DT, Costenbader KH, Jayne D, Dörner T, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Aringer M. Johnson SR, et al. Among authors: mosca m. J Rheumatol. 2019 Jul;46(7):721-726. doi: 10.3899/jrheum.180478. Epub 2018 Dec 15. J Rheumatol. 2019. PMID: 30554156
663 results